Type II cGMP-dependent protein kinase inhibits EGF-induced MAPK/JNK signal transduction in breast cancer cells

Oncology Reports

Volumn 27, Issue 6, 2012, Pages 2039-2044

  Lan, Ting ^a   Chen, Yongchang ^a   Sang, Jianrong ^a   Wu, Yan ^a   Wang, Ying ^a   Jiang, L U ^a   Tao, Yan ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

Apoptosis; Breast cancer cells; MAPK JNK; Signal transduction; Type II cGMP dependent protein kinase

Indexed keywords

CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE II; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; RAS PROTEIN; SOS PROTEIN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BINDING AFFINITY; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; NICK END LABELING; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; EPIDERMAL GROWTH FACTOR; FEMALE; GRB2 ADAPTOR PROTEIN; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 7; MAP KINASE SIGNALING SYSTEM; PHOSPHORYLATION; RAS PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SOS1 PROTEIN; THIONUCLEOTIDES;

EID: 84860785586     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1726     Document Type: Article

References (30)

1. Dougherty CJ, Kubasiak LA, Frazier DP, Li H, Xiong WC, Bishopric NH and Webster KA: Mitochondrial signals initiate the activation of c-Jun N-terminal kinase (JNK) by hypoxia-reoxygenation. FASEB J 18: 1060-1070, 2004. (Pubitemid 38859214)
2. Widmann C, Gibson S, Jarpe MB and Johnson GL: Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 79: 143-180, 1999. (Pubitemid 29056951)
3. Tournier C, Whitmarsh AJ, Cavanagh J, Barrett T and Davis RJ: Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase. Proc Natl Acad Sci USA 94: 7337-7342, 1997. (Pubitemid 27345316)
4. Barr RK and Bogoyevitch MA: The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs). Int J Biochem Cell Biol 33: 1047-1063, 2001. (Pubitemid 32817087)
5. Davis RJ: Signal transduction by the JNK group of MAP kinases. Cell 103: 239-252, 2000.
6. Chang L and Karin M: Mammalian MAP kinase signaling cascades. Nature 410: 37-40, 2001. (Pubitemid 32225829)
7. Dunn C, Wiltshire C, MacLaren A and Gillespie DA: Molecular mechanism and biological functions of c-Jun N-terminal kinase signalling via the c-Jun transcription factor. Cell Signal 14: 585-593, 2002. (Pubitemid 34304343)
8. Xia Z, Dickens M, Raingeaud J, Davis RJ and Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331, 1995.
9. Liu J and Lin A: Role of JNK activation in apoptosis: a double-edged sword. Cell Res 15: 36-42, 2005. (Pubitemid 41653963)
10. Orstavik S, Natarajan V, Taskén K, Jahnsen T and Sandberg M: Characterization of the human gene encoding the type Ialpha and type Ibeta cGMP-dependent protein kinase (PRKG1). Genomics 42: 311-318, 1997. (Pubitemid 27263762)
11. Orstavik S, Solberg R, Taskén K, et al: Molecular cloning, cDNAstructure and chromosomal localization of the human type IIcGMP-dependent protein kinase. Biochem Biophys Res Commun 220: 759-765, 1996. (Pubitemid 26198584)
12. Browing DD: Protein kinase G as a therapeutic target for the treatment of metastatic colorectal cancer. Expert Opin Ther Targets 12: 367-376, 2008.
13. Chen YC, Ren F, Sang JR, Tao Y and Xu WX: Type II cGMP-dependent protein kinase inhibits proliferation of the gastric cancer cell line BGC-823. Mol Med Rep 3: 361-366, 2010.
14. Wu Y, Chen YC, Qu R, Lan T and Sang JR: Type II cGMP-dependent protein kinase inhibits EGF-triggered signal transduction of the MAPK/ERK-mediated pathway in gastric cancer cells. Oncol Rep 27: 553-558, 2012.
15. Jiang H, Grenley MO, Bravo MJ, et al: EGFR/Ras/MAPK signaling mediates adult midgut epithelial homeostasis and regeneration in Drosophila. Cell Stem Cell 8: 84-95, 2011.
16. de Rooij J and Bos JL: Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras. Oncogene 14: 623-625, 1997.
17. Hofmann F: The biology of cyclic GMP-dependent protein kinases. J Biol Chem 280: 1-4, 2005.
18. Nie HG, Chen L, Han DY, et al: Regulation of epithelial sodium channels by cGMP/PKGII. J Physiol 587: 2663-2676, 2009.
19. Rangaswami H, Marathe N, Zhuang S, Chen Y, Yeh JC, Frangos JA, Boss GR and Pilz RB: Type II cGMP-dependent protein kinase mediates osteoblast mechanotransduction. J Biol Chem 284: 14796-14808, 2009.
20. Rangaswami H, Schwappacher R, Marathe N, et al: Cyclic GMP and protein kinase G control a Src-containing mechanosome in osteoblasts. Sci Signal 3: ra91, 2010.
21. Cook AL and Haynes JM: Protein kinase G II-mediated proliferative effects in human cultured prostatic stromal cells. Cell Signal 16: 253-261, 2004.
22. Swartling FJ, Ferletta M, Kastemar M, Weiss WA and Westermark B: Cyclic GMP-dependent protein kinase II inhibits cell proliferation, Sox9 expression and Akt phosphorylation in human glioma cell lines. Oncogene 28: 3121-3131, 2009.
23. Fallahian F, Karami-Tehrani F, Salami S and Aghaei M: Cyclic GMP induced apoptosis via protein kinase G in oestrogen receptor-positive and -negative breast cancer cell lines. FEBS J 278: 3360-3369, 2011.
24. Wells A: EGF receptor. Int J Biochem Cell Biol 31: 637-643, 1999.
25. Saito T, Okada S, Ohshima K, et al: Differential activation of epidermal growth factor (EGF) receptor downstream signaling pathways by betacellulin and EGF. Endocrinology 145: 4232-4243, 2004. (Pubitemid 39120572)
26. Hynes NE and MacDonald G: ErbB receptors and signaling pathways in cancer. Curr Opin Cell Biol 21: 177-184, 2009.
27. Normanno N, Bianco C, De Luca A, et al: Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment. Endocr Relat Cancer 10: 1-21, 2003. (Pubitemid 36457237)
28. Sharma SV, Bell DW, Settleman J, et al: Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer 7: 169-181, 2007.
29. Hu T and Li C: Convergence between Wnt-β-catenin and EGFR signaling in cancer. Mol Cancer 9: 236, 2010.
30. Quatrale AE, Porcelli L, Silvestris N, Colucci G, Angelo A and Azzariti A: EGFR tyrosine kinases inhibitors in cancer treatment: in vitro and in vivo evidence (Review). Front Biosci 16: 1962-1972, 2011.